In the News

Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), announced the launch of Ringza in Canada. The Population Council developed the one year contraceptive vaginal ring (which received U.S. FDA approval in 2018 as Annovera®) and licensed it to Duchesnay for market access. Ringza/Annovera is the first and only contraceptive to provide an entire year of protection against unintended pregnancy while fully under a woman’s control.

The boarding school has allowed girls and young women to complete their secondary education while supporting their children.

The Daily News shares reporting from AFP on the Council's research on persons with disabilities trafficked for begging.

Saumya Ramarao, Chair of the Council's Institutional Review Board, and Apoorva Jadhav, a senior fellow at the Population Reference Bureau, wrote for Think Global Health on the ways women leaders improve the health and well-being of all women worldwide.

Dr. Karen Austrian, Director of the Population Council’s Girl Innovation, Research, and Learning (GIRL) Center, speaks with The African Researcher.

A recent study by the Population Council in collaboration with the Ethiopian Lawyers with Disabilities Association and the Ethiopian Center for Disability and Development has found that many children with disabilities in Ethiopia are forced into beggary by traffickers who deceive families with false promises of care, education, or economic opportunity.

SwiftPharma BV announced a partnership with the Medicines Patent Pool and the Population Council under Project ELYRA, a collaborative initiative aimed at advancing development pathways and future access for Griffithsin (GRFT)-based products to prevent sexually transmitted infections (STIs), including HIV, HSV, HPV, gonorrhea, syphilis, and chlamydia.

Supreme Court Dobbs decision has contributed to surge of interest in male contraception